Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

被引:152
作者
Carozzi, Francesca [2 ]
Confortini, Massimo [2 ]
Dalla Palma, Paolo [3 ]
Del Mistro, Annarosa [4 ]
Gillio-Tos, Anna
De Marco, Laura
Giorgi-Rossi, Paolo [5 ]
Pontenani, Giovanni [2 ]
Rosso, Stefano
Sani, Cristina [2 ]
Sintoni, Catia [6 ]
Segnan, Nereo
Zorzi, Manuel [4 ]
Cuzick, Jack [7 ]
Rizzolo, Raffaella
Ronco, Guglielmo [1 ]
机构
[1] Ctr Canc Prevent, Canc Epidemiol Unit, I-10123 Turin, Italy
[2] Ctr Canc Study & Prevent, Florence, Italy
[3] Santa Chiara Hosp, Trento, Italy
[4] Venetian Oncol Inst IRCCS, Padua, Italy
[5] Laziosanita Agcy Publ Hlth, Rome, Italy
[6] Ravenna Hosp, AUSL Ravenna, Ravenna, Italy
[7] Queen Marys Sch Med & Dent & Canc Res UK, London, England
关键词
D O I
10.1016/S1470-2045(08)70208-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Human-papillomavirus (HPV) testing is more sensitive, but less specific, than conventional cytology for detecting high-grade cervical intraepithelial neoplasia. (CIN). We assessed whether HPV testing with triage by p16-INK4A overexpression. can increase specificity while maintaining sensitivity. Methods HPV-positive women were enrolled between June 10, 2003, and Dec 31, 2004 in a multicentre randomised controlled trial, which compared stand-alone HPV testing by Hybrid Capture 2 (experimental group) with conventional cytology, were referred for colposcopy. In seven of nine centres, cytospin preparations from these women were tested for p16-INK4A overexpression by immunostaining. The sensitivity and specificity for CIN grade 2 or more, determined at blind review of histology, were calculated for these women. We also estimated the relative sensitivity and relative referral to colposcopy that would have been obtained by HPV testing with p16-INK4A triage compared with conventional cytology. This trial is registered as a Standard Randomised Controlled Trial, number ISRCTN81678807. Findings 24661 women were randomly assigned to the experimental group. 1137 women (74% of those undergoing colposcopy in relevant centres), including 50 with CIN2 and 42 with CIN3 or cancer, had valid p16-INK4A immunostaining. For the endpoint of CIN2+, sensitivity and specificity of p16-INK4A (deemed positive with any number of stained cells-except endocervical, metaplastic, and atrophic cells if morphologically normal) in HPV-positive women of any age were 88% (81 of 92; 95% CI 80-94) and 61% (633 of 1045; 57-64), respectively. In the 35-60-year age group, the relative sensitivity of HPV testing and p16-INK4A triage versus conventional cytology for CIN2+ was 1.53 (95% CI 1.15-2.02) and relative referral was 1.08 (0.96-1.21). In the 25-34-year age group, relative sensitivity was 3.01 (1.82-5.17) and relative referral was 1.15 (0.96-1.37). In the latter age group, when 5% or more stained cells were deemed positive, the corresponding values were 2.06 (1.20-3.68) and 0.58 (0.46-0.73), respectively. Interpretation HPV testing with p16-INK4A triage produces a significant increase in sensitivity compared with conventional cytology, with no substantial increase in referral to colposcopy. Funding European Union, Italian Ministry of Health, Regional Health Administrations of Piemonte, Tuscany, Veneto, and Emilia-Romagna, and Public Health Agency of Lazio Region.
引用
收藏
页码:937 / 945
页数:9
相关论文
共 34 条
  • [1] p16INK4a expression correlates with degree of cervical neoplasia:: A comparison detection of high-risk with Ki-67 expression and HPV types
    Agoff, SN
    Lin, P
    Morihara, J
    Mao, C
    Kiviat, NB
    Koutsky, LA
    [J]. MODERN PATHOLOGY, 2003, 16 (07) : 665 - 673
  • [2] Role of P16(INK4A) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology
    Carozzi, F
    Cecchini, S
    Confortini, M
    Becattini, V
    Cariaggi, MP
    Pontenani, G
    Sani, C
    Ciatto, S
    [J]. CANCER CYTOPATHOLOGY, 2006, 108 (02) : 119 - 123
  • [3] CAROZZI F, 2005, AM J CLIN PATHOL, V124, P1
  • [4] Management of women who test positive for high-risk types of human papillomavirus: the HART study
    Cuzick, J
    Szarewski, A
    Cubie, H
    Hulman, G
    Kitchener, H
    Luesley, D
    McGoogan, E
    Menon, U
    Terry, G
    Edwards, R
    Brooks, C
    Desai, M
    Gie, C
    Ho, L
    Jacobs, I
    Pickles, C
    Sasieni, P
    [J]. LANCET, 2003, 362 (9399) : 1871 - 1876
  • [5] Overview of the European and North American studies on HPV testing in primary cervical cancer screening
    Cuzick, Jack
    Clavel, Christine
    Petry, Karl-Ulrich
    Meijer, Chris J. L. M.
    Hoyer, Heike
    Ratnam, Samuel
    Szarewski, Anne
    Birembaut, Philippe
    Kulasingam, Shalini
    Sasieni, Peter
    Iftner, Thomas
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) : 1095 - 1101
  • [6] New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections
    Doeberitz, MV
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (17) : 2229 - 2242
  • [7] New molecular tools for efficient screening of cervical cancer
    Doeberitz, MV
    [J]. DISEASE MARKERS, 2001, 17 (03) : 123 - 128
  • [8] P16INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix.: I:: Experience with squamous lesions in 189 consecutive cervical biopsies
    Dray, M
    Russell, P
    Dalrymple, C
    Wallman, N
    Angus, G
    Leong, A
    Carter, J
    Cheerala, B
    [J]. PATHOLOGY, 2005, 37 (02) : 112 - 124
  • [9] The predictive value of p16INK4a and hybrid capture 2 human papillomavirus testing for high-grade cervical intraepithelial neoplasia
    Guo, M
    Hu, LL
    Baliga, M
    He, Z
    Hughson, MD
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (06) : 894 - 901
  • [10] A comparison of the clinical utility of p16INK4a immunolocalization with the presence of human papillomavirus by Hybrid Capture 2 for the detection of cervical dysplasia/neoplasia
    Holladay, E. Blair
    Logan, Sarah
    Arnold, Jeffrey
    Knesel, Brad
    Smith, G. Denice
    [J]. CANCER CYTOPATHOLOGY, 2006, 108 (06): : 451 - 461